Nội nha tái tạo: tổng quan toàn diện

A Comprehensive Report on Regenerative Endodontics: Biological Paradigms, Clinical Realities, and Future Frontiers Part 1: The Paradigm Shift in Endodontic Therapy 1.1 Introduction: Defining Regenerative Endodontics (REPs) Regenerative Endodontics represents one of the most significant and transformative developments in modern dentistry, embodying a fundamental shift in treatment philosophy. Formally, Regenerative Endodontic Procedures (REPs) are defined as biologically based procedures designed to replace damaged and diseased pulp tissue with healthy, viable, functional tissue. This approach leverages the principles of tissue engineering to restore the root canal system to a healthy state, allowing for the continued physiological development of the root and its surrounding tissues. This field signifies a "paradigm shift" away from the traditional endodontic model. For over a century, conventional root canal therapy has been predicated on a surgical model of repair: the complete extirpation of all pulp tissue, chemo-mechanical disinfection, and the obturation (filling) of the resulting sterile space with an inert, biocompatible material such as gutta-percha. REPs, by contrast, are based on a medical model of regeneration. The ambition is not to fill a void, but to foster true biological healing and restore a living, functional pulp-dentin complex. This developing area of practice is recognized by the specialty's leading bodies. The American Association of Endodontists (AAE) has adopted the term "regenerative endodontic procedures" and formally recognizes it within the scope of endodontics. The European Society of Endodontology (ESE) refers to this biologically based approach as "revitalization". Regardless of the terminology, this philosophy represents the ultimate ambition of the specialty: to transition fully from a model of surgical repair to one of true biological restoration, thereby fulfilling the highest ideal of the dental profession—to preserve the natural dentition in its most healthy and functional state. 1.2 The Clinical Imperative: The Challenge of the Necrotic Immature Tooth The impetus for the development of REPs arose from a specific and profound clinical challenge: the necrotic, immature permanent tooth. This condition typically occurs in young patients when deep dental caries or, more commonly, traumatic injury causes the dental pulp to become necrotic before root development (apexogenesis) is complete. The pathobiology of this state presents two distinct problems. The first is the "open apex," a wide, non-constricted root end that makes achieving a conventional fluid-tight apical seal extraordinarily difficult. The second, and far more critical, problem is the tooth's structural immaturity. A tooth in this state is left with an unfavorable crown-to-root ratio and, most importantly, extremely thin and fragile dentinal walls. This structural fragility is the central weakness of traditional treatments. Even when a conventional procedure is deemed "successful"—that is, the infection is resolved and the apex is sealed—it fails to address this underlying biomechanical deficit. The tooth remains in its "successfully" sealed but "unsuccessfully" weak state, permanently arrested in its development. The primary long-term failure mechanism for these teeth is not endodontic re-infection, but catastrophic, non-restorable cervical root fracture. Therefore, a new treatment philosophy was required, one whose primary goal was not just microbiological control, but structural reinforcement. REPs were developed specifically to meet this biomechanical imperative. The procedure is designed to create a vital tissue complex within the canal that can resume its original developmental function, allowing for the continued thickening of the dentinal walls and an increase in root length. This process results in a stronger, more fracture-resistant tooth, offering a true long-term solution that traditional methods cannot provide. 1.3 Establishing the Terminology: REPs vs. Apexification vs. Apexogenesis To understand the precise role of REPs, it is essential to differentiate them from two related, and often confused, clinical procedures: apexogenesis and apexification. The key determinant is the vitality of the dental pulp.

Apexogenesis: This is a vital pulp therapy. It is the treatment of choice for an immature permanent tooth with an exposed or inflamed but still VITAL pulp. The goal is to preserve the vitality of the remaining pulp tissue, particularly the apical portion, to allow it to continue its natural physiological function and complete the formation of the root. In this procedure, a biocompatible material, such as Mineral Trioxide Aggregate (MTA) or Biodentine, is placed directly onto the vital pulp (a procedure known as a pulpotomy) to protect it and allow it to heal. If successful, the tooth simply continues to mature on its own.
Apexification: This is the traditional treatment for a necrotic, immature permanent tooth. Because the pulp is dead, natural root development has permanently ceased. The goal of apexification is not regeneration; it is the induction of a non-vital hard-tissue barrier (a "calcified barrier") at the open root apex.
Traditional Method: This involved placing calcium hydroxide, Ca(OH)_{2}, as a medicament inside the root canal for a long period (6-18 months), with multiple replacement appointments, until a calcified barrier was radiographically visible.
Modern Method: The preferred modern technique is the creation of an immediate "MTA plug." In this one- or two-visit procedure, MTA is placed at the root end to create an immediate, artificial apical barrier.
The Critical Limitation: Regardless of the method, apexification provides no benefit for continued root development. It seals the apex but leaves the tooth with the same thin, fracture-prone walls identified as the core clinical problem.
Regenerative Endodontic Procedures (REPs): Like apexification, REPs are indicated for a necrotic, immature permanent tooth. However, REPs are the biological alternative to apexification's mechanical solution. Instead of creating an inert barrier, the goal is to regenerate a functional pulp-dentin complex that can resume root development, thicken the dentinal walls, and strengthen the tooth.

Part 2: The Biological Foundation of Tissue Regeneration 2.1 The Tissue Engineering Triad: A Framework for Regeneration Regenerative endodontics is a direct clinical application of the principles of tissue engineering. The potential to regenerate the complex pulp-dentin structure is not theoretical; it is based on the orchestrated interaction of three core biological components, commonly known as the "Tissue Engineering Triad". 1. Stem Cells: The "building blocks" or progenitor cells capable of differentiating into the specialized cells (e.g., odontoblast-like cells) required to form new tissue. 2. Scaffolds: A three-dimensional, biodegradable structural framework that houses the stem cells, mimics the natural extracellular matrix (ECM), and guides tissue formation. 3. Growth Factors (Signaling Molecules): The bioactive proteins or morphogens that act as the "biological instructions," signaling the stem cells to migrate, proliferate, and differentiate. The entire clinical protocol for REPs, as detailed in Part 3, is a carefully designed procedure to recruit, stimulate, or deliver all three of these components into the disinfected root canal space. 2.2 Stem Cells: The Cellular Engine REPs rely on the activity of mesenchymal stem cells (MSCs), which are multipotent and hold the potential to form dentin, pulp, and other connective tissues. In the most common REP protocol, these cells are endogenous, meaning they are from the patient's own body. They are not typically harvested and placed into the canal; rather, they are "recruited" from the periapical tissues in a process known as "cell homing". The primary cellular source for this procedure is the Stem Cells from the Apical Papilla (SCAP). The apical papilla is the soft tissue at the end of the developing root that contains a rich population of robust stem cells responsible for root formation. This tissue has a separate blood supply from the pulp and has been shown to remain vital even after the coronal and radicular pulp has become necrotic. This remarkable survivability makes SCAP the ideal cell source for regeneration. Other potential sources include any remaining Dental Pulp Stem Cells (DPSCs) or Bone Marrow Stem Cells (BMSCs) from the surrounding alveolar bone. The "cell homing" mechanism is a deliberate clinical step. During the second appointment, the clinician intentionally passes a sterile file just beyond the open apex to irritate the apical papilla, inducing controlled bleeding into the canal space. This "revived bleeding" is the critical event that physically carries the SCAP from the periapical tissues up into the root canal, where they are contained within the scaffold. 2.3 Scaffolds: The Structural Matrix The scaffold provides the 3D, porous, and biodegradable physical environment necessary for the recruited stem cells to attach, proliferate, and organize into a new, 3D tissue structure.

Autologous (Host-Derived) Scaffolds:
Blood Clot: This is the simplest, most common, and most clinically utilized scaffold. The bleeding induced in the second appointment is allowed to form a stable blood clot that fills the canal. This clot, rich in fibrin, is the scaffold. It is perfectly biocompatible, non-immunogenic, and serves as an excellent temporary matrix. Furthermore, it acts as a carrier, trapping the SCAP that were delivered with the bleeding and sequestering growth factors released by its own platelets.
Platelet Concentrates (PRF/PRP): Advanced autologous scaffolds such as Platelet-Rich Fibrin (PRF) and Platelet-Rich Plasma (PRP) are also used. These are prepared by centrifuging the patient's own venous blood. They function as a "super-scaffold," providing a more robust fibrin matrix that is pre-loaded with a significantly higher concentration of platelets and, consequently, growth factors.
Engineered Scaffolds: While not yet in routine clinical use, significant research is focused on developing engineered biomaterials, such as injectable hydrogels (e.g., GelMA), collagen, or synthetic polymers, that could one day offer better control over scaffold properties and growth factor delivery.

2.4 Growth Factors: The Signaling Molecules Growth factors are the bioactive signaling molecules that regulate every aspect of the regenerative process, including cell migration (chemotaxis), proliferation, and differentiation. The brilliance of the REP protocol is that it actively harvests these molecules from two distinct host sources. 1. From the Blood/Scaffold: The induced blood clot and, to a greater extent, platelet concentrates (PRP/PRF) are rich sources of platelet-released growth factors, such as Platelet-Derived Growth Factor (PDGF) and Transforming Growth Factor-beta (TGF-\beta). 2. From the Dentin Matrix: This is a more subtle and elegant aspect of the procedure's biological foundation. The dentin walls of the root canal are not inert; they are a natural "reservoir" where a wide array of growth factors are sequestered during tooth formation. These molecules are embedded within the mineralized matrix. A key part of the clinical protocol is designed to unlock this endogenous source of signaling molecules. The AAE guidelines specify a final irrigation step using a chelating agent, such as 17% Ethylenediaminetetraacetic acid (EDTA). The primary function of EDTA in this context is not disinfection. Its role is to gently demineralize the surface of the canal walls, which un-sequesters and releases these stored growth factors from the dentin matrix. This "conditioning" of the canal walls means that when the SCAP-filled blood clot (Source 1) is introduced, it is bathed in a "soup" of potent morphogens released from the dentin itself (Source 2). This combination of signals from both the clot and the dentin provides a powerful stimulus, instructing the stem cells to differentiate into odontoblast-like cells and begin forming a new hard-tissue matrix. The clinical procedure is, therefore, a precise act of in-situ biochemical manipulation, turning the tooth itself into a growth factor delivery system. Part 3: Clinical Protocols and Material Science 3.1 Evidence-Based Clinical Protocols (AAE & ESE) The clinical protocol for REPs has been standardized by endodontic specialty organizations and typically involves two or more appointments. The guiding philosophy of the protocol is to balance the need for disinfection with the need to preserve the vitality of the apical stem cells. First Appointment: Disinfection Phase The goal of this visit is to eliminate the microbial biofilm from the root canal system.

Anesthesia and Isolation: Local anesthesia is administered, followed by mandatory dental dam isolation. The AAE guidelines suggest considering an anesthetic agent without a vasoconstrictor (e.g., 3% mepivacaine) to avoid compromising the blood supply to the periapical tissues.
Access and Irrigation: A standard endodontic access is made. Irrigation must be copious but gentle. This step highlights the central tension of REPs: the conflict between disinfection and cytotoxicity. Conventional endodontics uses high-concentration (e.g., 5.25%) sodium hypochlorite (NaOCl) for its potent antimicrobial action. However, NaOCl is also highly cytotoxic to the delicate SCAP that are essential for regeneration.
Therefore, the REP protocol is a deliberate compromise. It calls for:

1. Lower Concentration NaOCl: Using 1.5% – 3% NaOCl (e.g., 20 mL/canal over 5 min) provides adequate disinfection while "minimiz[ing] cytotoxicity to stem cells in the apical tissues". 2. **Gentle Delivery: Irrigation is performed using a closed-end, side-vented needle that is positioned about 1 mm from the root end to prevent extrusion of the irrigant into the periapical tissues.

Instrumentation: Minimal to no instrumentation of the canal walls is performed. This is done to preserve the fragile, thin dentinal walls and to protect the vital SCAP and dentin-matrix growth factors.
Intracanal Medicament: After gentle drying with paper points, an intracanal medicament is placed to provide sustained disinfection (detailed in 3.2).
Sealing: The tooth is sealed with a robust temporary restoration (e.g., 3-4 mm of Cavit, IRM, or glass ionomer) to prevent re-infection. The patient is dismissed for 1-4 weeks.

Second Appointment: Tissue Stimulation & Sealing Phase

Assessment: The patient's signs and symptoms are assessed. If they persist, the disinfection phase may be repeated.
Anesthesia and Isolation: The tooth is anesthetized (again, without a vasoconstrictor to facilitate bleeding) and isolated.
Rinsing (Growth Factor Release): The temporary is removed, and the medicament is rinsed out. This is followed by the critical irrigation step: 17% EDTA (e.g., 20 mL/canal for 5 min). As established in Part 2, this chelating agent's primary role is to release the stored growth factors from the dentin walls.
Induction of Scaffold: The canal is dried. A sterile hand file is then intentionally passed 1-2 mm beyond the open apex to irritate the apical papilla and induce bleeding into the canal space.
Blood Clot Formation: The clinician waits for the canal to fill with blood up to the level of the Cemento-Enamel Junction (CEJ). This blood is allowed to clot, forming the vital scaffold.
Barrier Placement: A biocompatible barrier material, typically 3-4 mm thick, is carefully placed directly on top of the blood clot. This material is essential to seal and protect the regenerating tissue. (This is detailed in 3.3).
Final Restoration: A bonded, permanent restoration (e.g., composite resin) is placed over the barrier material. A high-quality, well-sealed coronal restoration is paramount to the long-term success of the procedure, as it prevents coronal microleakage, a major cause of endodontic failure.
Follow-up: The patient is monitored clinically and radiographically over several years to assess for signs of healing, resolution of the apical lesion, and, ideally, radiographic evidence of continued root development and a positive response to pulp vitality testing.

3.2 Analysis of Intracanal Medicaments: The Antibiotic vs. Calcium Hydroxide Debate The choice of intracanal medicament is a critical step, as it must provide sustained disinfection without compromising the regenerative potential or causing adverse side effects.

Triple Antibiotic Paste (TAP):
Composition: A mixture of ciprofloxacin, metronidazole, and minocycline.
Efficacy: It is a potent, broad-spectrum antimicrobial paste. The AAE recommends using a low concentration (1-5 mg/ml) and placing it below the CEJ.
Major Complication: Minocycline is a tetracycline, a class of antibiotics notorious for causing deep, intrinsic staining of tooth structure. This results in a highly unaesthetic gray discoloration of the crown, a severe drawback, especially in anterior teeth.
Calcium Hydroxide (Ca(OH)_{2}):
Efficacy: This is the workhorse medicament of traditional endodontics, known for its high pH and antimicrobial properties. It is listed as a primary alternative to TAP in the AAE guidelines.
Advantages: Its main advantage is that it does not cause coronal discoloration.
Debate: The clinical shift toward Ca(OH)_{2} has been driven almost entirely by the desire to prevent discoloration.
Alternatives: To balance the antimicrobial potency of TAP with the esthetic safety of Ca(OH)_{2}, alternative pastes have been developed. The most common is Double Antibiotic Paste (DAP), which simply omits the staining minocycline and contains only ciprofloxacin and metronidazole. Other formulations substituting minocycline with non-staining antibiotics like cefaclor or clindamycin are also under investigation.

3.3 The Role of Bioactive Barrier Materials The material placed over the blood clot must be biocompatible, non-toxic, and provide a durable, hermetic seal against bacterial invasion. This has led to the exclusive use of bioactive calcium silicate cements.

Mineral Trioxide Aggregate (MTA):
MTA was the original gold standard for REPs, as it was already the material of choice for apexification plugs and perforation repairs.
Advantages: It provides an excellent seal, is highly biocompatible, and is bioactive, meaning it actively stimulates the formation of hard tissue.
Disadvantages: It has several significant clinical drawbacks: a very long setting time (several hours), difficult handling characteristics, high cost , and, like TAP, it causes significant tooth discoloration. This staining is not from an antibiotic, but from the bismuth oxide (Bi_{2}O_{3}) that is added to the cement as a radiopacifier. Bismuth oxide is unstable and can oxidize or react with NaOCl or blood components to form black precipitates.
Modern Calcium Silicate Cements (e.g., Biodentine):
The complications associated with MTA led to the development of new-generation calcium silicate cements, such as Biodentine.
Advantages: These materials were designed to overcome MTA's specific flaws:

1. Esthetic Stability: They are bismuth-free. Biodentine, for example, uses zirconium oxide as its radiopacifier, which is stable and does not cause the gray staining seen with bismuth oxide. This is its single greatest advantage in REPs. 2. Fast Setting Time: They set in minutes (e.g., ~12 minutes for Biodentine) rather than hours, allowing the clinician to place the final bonded restoration in the same visit. 3. Improved Handling: They are generally easier to mix and place.

These materials retain the high biocompatibility, bioactivity, and excellent sealing ability of MTA , but without the major clinical and esthetic drawbacks. Their development has been integral to refining the REP protocol into a more predictable and esthetically safe procedure.

Part 4: Comparative Outcomes and Long-Term Prognosis 4.1 Defining Success: Clinical and Radiographic Outcomes To justify its use, REPs must demonstrate outcomes that are at least equivalent, if not superior, to the traditional standard of care, apexification. Decades of clinical research, including numerous systematic reviews and meta-analyses, have provided a clear picture of its efficacy.

Clinical Success (Healing): This is the primary goal, defined as the resolution of clinical signs and symptoms (e.g., pain, swelling, sinus tract) and the healing of apical periodontitis (the lesion in the bone).
On this metric, REPs perform exceptionally well. Studies consistently show high success and survival rates, typically greater than 85%, with some studies reporting rates as high as 93% or even 100% at 12 months.
This high success rate is not, in itself, the main argument for REPs. Multiple meta-analyses directly comparing REPs to apexification (both Ca(OH)_{2} and MTA plug techniques) have found comparable success and survival rates. The evidence does not show that REPs are superior to apexification at simply resolving infection.
This comparable success rate is, in fact, the most powerful finding. It demonstrates that the new, biological approach is just as reliable at infection control as the traditional, mechanical approach. This clinical equivalency provides the "permission" for clinicians to choose the REP protocol, which offers a profound secondary benefit that apexification cannot.
Radiographic Success (Strengthening): This secondary benefit is the true advantage of REPs and the entire reason for its adoption.
Continued Root Development: Multiple systematic reviews and meta-analyses have concluded that REPs are statistically superior to apexification in stimulating continued root maturation, defined as an increase in root length and, most critically, an increase in dentinal wall thickness.
Apexification, by contrast, shows no such development.
This radiographic evidence directly translates to the biomechanical goal established in Part 1. By thickening the fragile dentinal walls, REPs create a stronger, more fracture-resistant tooth, directly addressing the primary long-term failure mechanism of immature teeth.
Return of Vitality: This outcome is more variable. While the goal is a "vital" pulp, and some studies report a high percentage of positive responses to cold or electric pulp testing after REPs, other meta-analyses find this outcome unpredictable.

4.2 Table 1: Comparative Analysis: Apexification vs. Regenerative Endodontic Procedures (REPs) The following table synthesizes the evidence from numerous studies to provide a clear, head-to-head comparison for clinical decision-making. Metric Apexification (Modern MTA-Plug) Regenerative Endodontic Procedures (REPs) Pulp Status Necrotic Necrotic Primary Goal Creation of an artificial, calcified apical barrier. Regeneration of a vital, functional pulp-dentin complex. Mechanism Induction of a hard tissue barrier (or placement of an artificial plug). Tissue engineering (cell homing of SCAP, scaffold, growth factors). Clinical Success Rate High (>85%) High (>85%) Tooth Survival Rate High (Comparable to REPs) High (Comparable to Apexification) Continued Root Length No Yes (Statistically significant increase) Dentinal Wall Thickness No Yes (Statistically significant increase) Long-Term Prognosis Guarded; tooth remains thin and is at high risk of cervical fracture. Favorable; tooth becomes stronger and more fracture-resistant. Common Complications Long-term root fracture. Coronal discoloration; unpredictable tissue type (repair vs. regeneration). 4.3 Long-Term Prognosis and Case Selection

Indications: The procedure is clearly indicated for a necrotic immature permanent tooth with an open apex. Case selection is critical. The ideal patient is young (typically 8-16 years old) with a viable apical papilla (SCAP). Good patient and parental cooperation is essential due to the multi-visit nature and long-term follow-up.
Contraindications:
Deciduous (primary) teeth, due to the risk of interfering with the erupting permanent successor.
Teeth with extensive calcifications or root canal anatomy that is inaccessible for disinfection.
Patients with severe, uncontrolled systemic conditions or compromised immune function that would impede healing.
Known allergies to the materials (e.g., antibiotics).
Patient non-compliance or significant dental anxiety.
Prognosis: The long-term prognosis for teeth treated with REPs is generally favorable. Follow-up studies at 8 and 11 years have shown continued root development and sustained clinical success. However, late-term complications, though rare, can occur. These teeth may be susceptible to external invasive cervical resorption, particularly if subsequent orthodontic forces are applied.

Part 5: Complications, Limitations, and Mitigation Strategies Despite its high success rate, REPs are not without limitations and complications. Decades of clinical application have revealed two primary challenges: the biological predictability of the regenerated tissue and the clinical complication of tooth discoloration. 5.1 The Challenge of Unpredictable Regeneration: Repair vs. Regeneration This is the primary biological limitation of current REP protocols. While the clinical goal is the "regeneration" of a functional, innervated, and vascularized pulp-dentin complex, histological (microscopic) analysis of treated human and animal teeth often shows that the new tissue formed is "repair" tissue rather than true regeneration. This repair tissue is frequently identified as a cementum-like hard tissue, bony islands, or a dense, fibrous connective tissue, rather than the organized, tubular structure of a true pulp-dentin complex. This histological finding explains the variable response to pulp vitality testing. It is critical to understand that this is not a "clinical failure". This repair tissue, even if it is not pulp, is still a vital, host-derived tissue that successfully fills the canal, facilitates the resolution of apical periodontitis, and, most importantly, induces the desired thickening of the root walls. This indicates that the current "cell homing" approach is highly effective for achieving the clinical and biomechanical goals, even if it does not yet achieve true, complete regeneration of the original tissue. 5.2 A Critical Analysis of Coronal Discoloration This is, by far, the most significant and frequently reported clinical complication of REPs. A systematic review found that approximately 54% of teeth in the included studies exhibited some degree of postoperative discoloration. This problem is magnified by the fact that the primary indication for REPs (traumatic injury) often involves anterior teeth in young patients, where aesthetics are of paramount concern. Intensive research into this complication has identified three primary etiological sources: 1. Intracanal Medicament (Minocycline): The tetracycline component of traditional Triple Antibiotic Paste (TAP) is a primary culprit. Minocycline is well-known to chelate calcium and incorporate into the dentin matrix, causing a deep, intrinsic, grayish-brown stain that is extremely difficult to remove. 2. Barrier Material (Bismuth Oxide): The radiopacifier in traditional MTA (both Grey and White formulations) is bismuth oxide. This compound is unstable in a biological environment. When it comes into contact with blood (the scaffold), collagen, or NaOCl, it can oxidize and form black metallic precipitates, staining the tooth structure from within. 3. The Scaffold (Blood): The blood clot itself, while necessary, can be a source of staining if red blood cells are pushed into the dentinal tubules, lyse, and degrade, leaving iron (from hemoglobin) deposits. 5.3 Evidence-Based Mitigation and Management The prevalence and severity of discoloration threatened the clinical adoption of REPs. This challenge directly drove innovation in material science and modifications to the clinical protocol. The evolution of REPs is a clear case study in how a procedure's complications can force its refinement. The first-generation protocols, which logically used the most potent materials (TAP for disinfection, MTA for sealing), were biologically successful but often esthetically disastrous. This led to the development of second-generation protocols focused entirely on prevention. Prevention (Medicaments): The most effective strategy is to avoid minocycline. This is achieved by:

Using Calcium Hydroxide (Ca(OH)_{2}) as the intracanal medicament. It is effective and does not stain.
Using a Double Antibiotic Paste (DAP), which contains only ciprofloxacin and metronidazole.

Prevention (Barrier Materials): The most effective strategy is to avoid bismuth oxide.

This is achieved by using a modern, bismuth-free calcium silicate cement.
Biodentine, which uses stable zirconium oxide as its radiopacifier, is the most-cited alternative and has been shown in multiple studies to cause significantly less or no discoloration compared to MTA. This material advantage was a direct response to the failures of MTA in this application.

Prevention (Clinical Technique):

Clinicians are advised to place the medicament and barrier material below the CEJ to keep them out of the visible crown.
Sealing the pulp chamber with a dentin bonding agent before placing the medicament has been proposed to block the dentinal tubules.
Some studies suggest that using PRF as a scaffold may result in less discoloration than an uncontrolled blood clot.

Management (Bleaching):

If discoloration does occur, internal bleaching is a treatment option.
However, systematic reviews have shown that bleaching is only partially effective and often cannot restore the original tooth color, particularly for deep, minocycline-induced stains. This reinforces the conclusion that prevention is the only reliable strategy.

5.4 Table 2: Clinical Guide to Etiology and Prevention of Discoloration in REPs This table provides a clear, actionable guide for clinicians to mitigate the primary complication of REPs, synthesizing evidence from numerous material science and clinical studies. Source of Discoloration Material Causative Agent Prevention Strategy Intracanal Medicament Triple Antibiotic Paste (TAP) Minocycline (a tetracycline) Do not use TAP. • Substitute with Calcium Hydroxide (Ca(OH)_{2}). • Substitute with Double Antibiotic Paste (DAP) (omits minocycline). Coronal Barrier Material Mineral Trioxide Aggregate (MTA) (Grey or White) Bismuth Oxide (radiopacifier) Do not use Bismuth-containing materials. • Substitute with a Bismuth-free material, such as Biodentine (uses Zirconium Oxide). Regenerative Scaffold Blood Clot Hemoglobin / RBCs

Ensure blood clot remains at/below CEJ. • Consider using Platelet-Rich Fibrin (PRF) as an alternative scaffold.

Part 6: The Future Frontier: From Regeneration to Bioengineering 6.1 The Evolving Goal: True Biological Restoration The field of regenerative endodontics is evolving along two parallel tracks. The first track is the perfection of in-situ regeneration for salvaging existing teeth. As established, the current "cell homing" approach is effective but biologically unpredictable, often resulting in "repair" (cementum, bone) rather than true "regeneration" of an innervated pulp-dentin complex. The future of this track is focused on closing this gap. This will involve moving from "cell homing" (recruiting) to "cell-based" approaches (delivering). Future protocols may involve:

Stem Cell Delivery: Harvesting the patient's own autologous DPSCs or SCAP, expanding them in a lab, and delivering a high concentration of them directly into the canal.
Advanced Scaffolds: Developing "smart" injectable hydrogels that can be pre-loaded with the precise cocktail of growth factors needed to reliably direct the stem cells to differentiate into odontoblasts and pulp fibroblasts, not bone cells.
Controlled Growth Factor Delivery: Identifying and delivering the specific signaling molecules to orchestrate the formation of blood vessels (angiogenesis) and nerves (neurogenesis).

This research track aims to achieve the "perfect" endodontic outcome: not a canal filled with gutta-percha, but a tooth whose pulp space has been fully and predictably regenerated with living, functional, and vital tissue. 6.2 The Next Generation: Whole Tooth Bioengineering The second, more ambitious track for regenerative dentistry moves beyond repairing a tooth to replacing it entirely with a bioengineered, living organ. This represents the future ex-vivo (out of the body) fabrication of a new tooth to replace one that is unsalvageable or already lost. This field is grounded in developmental biology and our understanding of the epithelial-mesenchymal interactions that guide tooth formation in the embryo. Pre-clinical studies have already shown remarkable progress:

Researchers have used adult stem cells (both bone-marrow-derived and dental-derived) to regenerate dentin-like tissues.
A novel "organ germ method" has been developed. This 3D cell manipulation technique cultures epithelial and mesenchymal cells in a way that mimics natural organogenesis, successfully creating a bioengineered tooth germ.
When this bioengineered tooth germ is transplanted into an animal model, it has been shown to erupt, form a structurally correct tooth (with crown, root, pulp, and periodontal ligament), and become a functional organ capable of mastication and responding to stimuli.

While this "holy grail" of tooth replacement is still in its infancy and faces enormous technical and regulatory hurdles, it is no longer theoretical. It represents the long-term ambition of the specialty. 6.3 Conclusion: The Trajectory of a Biological Specialty The evolution of endodontics is a clear progression from a mechanical craft to a biological science. The specialty began with a purely surgical model of extirpation and obturation. The development of bioactive materials like MTA and Biodentine ushered in an era of bioactive repair and vital pulp preservation. Regenerative Endodontic Procedures (REPs) represent the current clinical frontier: a shift to in-situ regeneration. REPs have successfully solved the critical biomechanical problem of the necrotic immature tooth, providing a viable, evidence-based treatment that not only heals infection but also strengthens the tooth against fracture—an outcome traditional apexification could never achieve. The future, represented by whole tooth bioengineering, aims for the specialty's ultimate goal: true biological creation. This trajectory positions regenerative endodontics not only as an alternative to apexification, but as the long-term biological competitor to the entire field of mechanical dental implants. The fundamental mission of endodontics is to preserve the natural dentition. REPs achieve this by saving teeth that would otherwise be lost. Whole tooth bioengineering, if realized, will fulfill this mission by replacing lost teeth not with titanium, but with a living, vital, and truly "natural" biological equivalent. Works cited 1. Endodontic Treatment: A Comprehensive Study, https://drive.google.com/open?id=1pxNrZdfvlX6d4L5uZW5NaZ57qEZICCpdNvTCokSqvlc 2. Regenerative endodontics – Wikipedia, https://en.wikipedia.org/wiki/Regenerative_endodontics 3. Endodontics: Procedures, Instruments, and Technolo…, https://drive.google.com/open?id=1V2lmGqix5qnHFd6QG1XiDxbiVMJVpOoNuBtBP90qAZo 4. Regenerative Endodontics and Minimally Invasive Dentistry: Intertwining Paths Crossing Over Into Clinical Translation – PMC, https://pmc.ncbi.nlm.nih.gov/articles/PMC8860982/ 5. A review of regenerative endodontics: current protocols and future directions – PMC, https://pmc.ncbi.nlm.nih.gov/articles/PMC5750827/ 6. Apexogenesis: Study, Cases, Procedure, Complications, https://drive.google.com/open?id=1t0Jn4fD18H_KQTD92ICtWXi9C2tl5jo9O7r9TQzPs5Y 7. Expert consensus on regenerative endodontic procedures – PMC – NIH, https://pmc.ncbi.nlm.nih.gov/articles/PMC9712432/ 8. Regenerative Endodontics – American Association of Endodontists, https://www.aae.org/specialty/clinical-resources/regenerative-endodontics/ 9. Clinical Guidelines Position Statements – American Association of Endodontists, https://www.aae.org/specialty/clinical-resources/guidelines-position-statements/ 10. Regenerative Endodontics: Advances and Clinical Protocols – European Society of Medicine, https://esmed.org/regenerative-endodontics-advances-and-clinical-protocols/ 11. Regenerative Endodontics as the Future Treatment of Immature Permanent Teeth – MDPI, https://www.mdpi.com/2076-3417/11/13/6211 12. Apexification with Calcium Hydroxide vs. Revascularization – PMC – PubMed Central, https://pmc.ncbi.nlm.nih.gov/articles/PMC7275243/ 13. Present status and future directions: Apexification – PMC – PubMed Central, https://pmc.ncbi.nlm.nih.gov/articles/PMC11525894/ 14. A Prospective Study of Long-Term Regenerative Endodontics Outcomes of Necrotic Immature Permanent Teeth: An 8-Year Follow-Up – PubMed, https://pubmed.ncbi.nlm.nih.gov/34946396/ 15. Efficacy of Regenerative Endodontics in Treating Immature Permanent Teeth: A Study of Long-Term Outcomes, https://cmegeriatricmed.co.uk/article/efficacy-of-regenerative-endodontics-in-treating-immature-permanent-teeth-a-study-of-long-term-outcomes-1019/ 16. Apexification in Austin, TX – Austin Center Endodontics, https://www.austincenterendo.com/procedures/endodontics/apexification-austin-tx 17. Apexification and Apexogenesis – Advanced Endodontics of New Haven, https://www.newhavenendo.com/apexification-and-apexogenesis 18. Apexification – Root Canal Specialty Associates, https://rootcanaldocs.com/treatment/apexification/ 19. Ingles_Endodontics.pdf, https://drive.google.com/open?id=1TQqINrsy8418UeJ0MW2-wFvmvQaV0j0v 20. Endodontic Regeneration Therapy: Current Strategies and Tissue Engineering Solutions, https://www.mdpi.com/2073-4409/14/6/422 21. Current overview on challenges in regenerative endodontics – PMC – PubMed Central, https://pmc.ncbi.nlm.nih.gov/articles/PMC4313471/ 22. Clinical Outcome and Comparison of Regenerative and Apexification Intervention in Young Immature Necrotic Teeth—A Systematic Review and Meta-Analysis – PubMed Central, https://pmc.ncbi.nlm.nih.gov/articles/PMC9267570/ 23. Coronal tooth discoloration induced by regenerative endodontic treatment using different scaffolds and intracanal coronal barriers: a 6-month ex vivo study, https://rde.ac/journal/view.php?doi=10.5395/rde.2019.44.e25 24. Effectiveness of Teeth Whitening after Regenerative Endodontics Procedures: An In Vitro Study – MDPI, https://www.mdpi.com/2077-0383/11/23/7016 25. AAE Clinical Considerations for a Regenerative Procedure Revised …, https://www.aae.org/specialty/wp-content/uploads/sites/2/2021/08/ClinicalConsiderationsApprovedByREC062921.pdf 26. Regenerative endodontic treatment: A systematic review of successful clinical cases. – Dental and Medical Problems, https://dmp.umw.edu.pl/en/article/2021/58/4/555/ 27. Alternative to Avoid Tooth Discoloration after Regenerative Endodontic Procedure: A Systematic Review – PubMed, https://pubmed.ncbi.nlm.nih.gov/30517438/ 28. Alternative to Avoid Tooth Discoloration after Regenerative Endodontic Procedure: A Systematic Review – SciELO, https://www.scielo.br/j/bdj/a/xZvN8ZskDdrXTgkbY8bpPvR/?lang=en 29. Discoloration of teeth due to different intracanal medicaments – Restorative Dentistry & Endodontics, https://rde.ac/journal/view.php?doi=10.5395/rde.2019.44.e10 30. Discoloration after Regenerative Endodontic Procedures: A Critical Review – PMC – NIH, https://pmc.ncbi.nlm.nih.gov/articles/PMC6064034/ 31. Alternative to Avoid Tooth Discoloration after Regenerative Endodontic Procedure: A Systematic Review – Semantic Scholar, https://pdfs.semanticscholar.org/7b2c/ced4c2290cf7e6cd3aa2083a393caf80c03a.pdf 32. (PDF) Comparative analysis of tooth discoloration induced by conventional and modified triple antibiotic pastes used in regenerative endodontics – ResearchGate, https://www.researchgate.net/publication/338576583_Comparative_analysis_of_tooth_discoloration_induced_by_conventional_and_modified_triple_antibiotic_pastes_used_in_regenerative_endodontics 33. The Efficacy of Different Antibiotic Compounds in Regenerative Treatment of Immature Necrotic Teeth – PMC – PubMed Central, https://pmc.ncbi.nlm.nih.gov/articles/PMC10985510/ 34. Alternative to Avoid Tooth Discoloration after Regenerative Endodontic Procedure: A Systematic Review – ResearchGate, https://www.researchgate.net/publication/329333913_Alternative_to_Avoid_Tooth_Discoloration_after_Regenerative_Endodontic_Procedure_A_Systematic_Review 35. EndoExcellence: From Preservation to Regeneration & Effective Use of CBCT, https://drive.google.com/open?id=1yvVD50Le7eeEM3gn5asezJt-tDgvbv5EODYHkFBriZc 36. MTA versus Biodentine: Review of Literature with a Comparative Analysis – PMC – NIH, https://pmc.ncbi.nlm.nih.gov/articles/PMC5620936/ 37. Biodentine VS MTA: A comparitive analysis – Int J Oral Health Dent, https://ijohd.org/archive/volume/6/issue/3/article/12133 38. Tooth Discoloration after Regenerative Endodontic Procedures with Calcium Silicate-Based Cements—An Ex Vivo Study – MDPI, https://www.mdpi.com/2076-3417/10/17/5793 39. Prevention and Correction of Tooth Discoloration due to Regenerative Endodontic Treatment | Khon Kaen University Dental Journal – ThaiJO, https://he01.tci-thaijo.org/index.php/KDJ/article/view/253890 40. A Comparison of Coronal Tooth Discoloration Elicited by Various Endodontic Reparative Materials MTA Plus, Bio MTA+, and Biodentine: An Ex Vivo Study – PubMed Central, https://pmc.ncbi.nlm.nih.gov/articles/PMC7887184/ 41. Vital Pulp Therapy in Aesthetic Zone-Identifying the Biomaterial That Reduces the Risk of Tooth Discolouration – PMC – PubMed Central, https://pmc.ncbi.nlm.nih.gov/articles/PMC8539990/ 42. (PDF) A Comparison of Coronal Tooth Discoloration Elicited by Various Endodontic Reparative Materials MTA Plus, Bio MTA+, and Biodentine: An Ex Vivo Study – ResearchGate, https://www.researchgate.net/publication/348837181_A_Comparison_of_Coronal_Tooth_Discoloration_Elicited_by_Various_Endodontic_Reparative_Materials_MTA_Plus_Bio_MTA_and_Biodentine_An_Ex_Vivo_Study 43. Comparative outcomes and success rates of regenerative endodontics versus traditional root canal therapy: A systematic review and meta-analysis – PubMed Central, https://pmc.ncbi.nlm.nih.gov/articles/PMC12475698/ 44. Evaluation of the Clinical Outcomes of Regenerative Endodontic Procedures Using Autologous Platelet Concentrate: A Systematic Review and Meta-Analysis – SciELO, https://www.scielo.br/j/pboci/a/jdHCtY3HWpvdzcCTWc9CskC/ 45. Comparative Effectiveness of Regenerative Endodontic Treatment Versus Apexification for Necrotic Immature Permanent Teeth With or Without Apical Periodontitis: An Umbrella Review – PubMed, https://pubmed.ncbi.nlm.nih.gov/39692071/ 46. Clinical Outcome and Comparison of Regenerative and Apexification Intervention in Young Immature Necrotic Teeth—A Systematic Review and Meta-Analysis – Semantic Scholar, https://www.semanticscholar.org/paper/Clinical-Outcome-and-Comparison-of-Regenerative-and-Panda-Mishra/bac83ce7721281c8541224da8fd835fa5ade12a6 47. Evaluation of the Clinical Outcomes of Regenerative Endodontic Procedures Using Autologous Platelet Concentrate – SciELO, https://www.scielo.br/j/pboci/a/jdHCtY3HWpvdzcCTWc9CskC/?lang=en&format=pdf 48. A review of the regenerative endodontic treatment procedure – PMC – NIH, https://pmc.ncbi.nlm.nih.gov/articles/PMC4534721/ 49. Contraindications for Single-Visit Regenerative Endodontic – Scribd, https://www.scribd.com/document/698510376/contraindications 50. Long-term Complications of Previously Successful Regenerative Endodontic Procedures after Orthodontic Movement: A Report of 3 Different Complications after 4, 8, and 11 Years – PubMed, https://pubmed.ncbi.nlm.nih.gov/35405157/ 51. Discoloration after Regenerative Endodontic Procedures: A Critical Review – PubMed, https://pubmed.ncbi.nlm.nih.gov/30083194/

⚠️ Thông tin kỹ thuật: Nội dung trong bài viết này chỉ mang tính chất tham khảo kỹ thuật dành cho chuyên gia nha khoa. Việc lắp đặt và sử dụng thiết bị y tế phải tuân thủ đúng hướng dẫn của nhà sản xuất và thực hiện bởi nhân viên được đào tạo. Liên hệ ANH & EM để được hỗ trợ kỹ thuật cụ thể.